Crinetics Pharmaceuticals, Inc. (CRNX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 10.73M | 6.16M | 143K | 1.03M | 361K | 0 | 0 | 399K | 640K | 0 | 346K | 988K | 2.68M | 709K | 458K | 439K | 3.13M | 1.08M | 0 | 0 |
| Revenue Growth % | 2873.41% | - | - | 158.4% | -43.59% | - | -100% | -59.62% | -76.11% | -100% | -24.45% | 125.06% | -14.44% | -34.23% | - | - | - | - | - | - |
| Cost of Goods Sold | 200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 1.86% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 10.53M | 6.16M | 143K | 1.03M | 361K | 0 | 0 | 399K | 640K | 0 | 346K | 988K | 2.68M | 709K | 458K | 439K | 3.13M | 1.08M | 0 | 0 |
| Gross Margin % | 98.14% | 100% | 100% | 100% | 100% | - | - | 100% | 100% | - | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | - | - |
| Gross Profit Growth % | 2818.01% | - | - | 158.4% | -43.59% | - | -100% | -59.62% | -76.11% | -100% | -24.45% | 125.06% | -14.44% | -34.23% | - | - | - | - | - | - |
| Operating Expenses | 150.91M | 139.83M | 142.73M | 130.14M | 111.77M | 94.75M | 87.8M | 83.18M | 74.17M | 62.66M | 59.32M | 53.98M | 50.66M | 48.27M | 43.91M | 43.48M | 36.96M | 31.97M | 27.81M | 26.09M |
| OpEx % of Revenue | 1405.93% | 2269.55% | 99810.49% | 12622.99% | 30960.11% | - | - | 20847.62% | 11588.91% | - | 17145.38% | 5463.87% | 1890.89% | 6807.48% | 9587.77% | 9905.24% | 1180.39% | 2965.31% | - | - |
| Selling, General & Admin | 50.83M | 53.7M | 52.27M | 49.84M | 35.53M | 28.18M | 25.89M | 24.84M | 20.83M | 17.08M | 15.48M | 13.34M | 12.19M | 11.27M | 11.93M | 10.49M | 8.71M | 7.36M | 6.23M | 5.6M |
| SG&A % of Revenue | 473.55% | 871.58% | 36548.95% | 4834.34% | 9841% | - | - | 6225.06% | 3254.38% | - | 4475.14% | 1350.51% | 454.98% | 1590.13% | 2603.71% | 2389.29% | 278.06% | 682.93% | - | - |
| Research & Development | 100.08M | 85.05M | 90.46M | 80.3M | 76.24M | 66.57M | 61.91M | 58.34M | 53.34M | 45.58M | 43.84M | 40.64M | 38.47M | 36.99M | 31.99M | 32.99M | 28.25M | 24.6M | 21.58M | 20.49M |
| R&D % of Revenue | 932.37% | 1380.51% | 63261.54% | 7788.65% | 21119.11% | - | - | 14622.56% | 8334.53% | - | 12670.23% | 4113.36% | 1435.91% | 5217.35% | 6984.06% | 7515.95% | 902.33% | 2282.37% | - | - |
| Other Operating Expenses | 0 | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -140.38M | -133.67M | -142.59M | -129.11M | -111.41M | -94.75M | -87.8M | -82.78M | -73.53M | -62.66M | -58.98M | -52.99M | -47.98M | -47.56M | -43.45M | -43.05M | -33.83M | -30.89M | -27.81M | -26.09M |
| Operating Margin % | -1307.79% | -2169.55% | -99710.49% | -12522.99% | -30860.11% | - | - | -20747.62% | -11488.91% | - | -17045.38% | -5363.87% | -1790.89% | -6707.48% | -9487.77% | -9805.24% | -1080.39% | -2865.31% | - | - |
| Operating Income Growth % | -26.01% | -41.08% | -62.4% | -55.96% | -51.51% | -51.21% | -48.87% | -56.21% | -53.26% | -31.76% | -35.72% | -23.12% | -41.83% | -53.96% | -56.27% | -64.99% | -47.6% | -41.75% | -50.71% | -54.11% |
| EBITDA | -139.22M | -132.67M | -141.57M | -128.15M | -110.48M | -93.96M | -87.03M | -82.03M | -73.06M | -62.4M | -58.7M | -52.72M | -47.7M | -47.28M | -43.21M | -42.83M | -33.59M | -30.65M | -27.57M | -25.86M |
| EBITDA Margin % | -1296.98% | -2153.42% | -99002.8% | -12429.97% | -30603.88% | - | - | -20558.9% | -11414.84% | - | -16966.47% | -5335.53% | -1780.33% | -6667.98% | -9433.62% | -9756.26% | -1072.72% | -2843.51% | - | - |
| EBITDA Growth % | -26.01% | -41.21% | -62.68% | -56.23% | -51.23% | -50.58% | -48.25% | -55.61% | -53.17% | -31.98% | -35.87% | -23.08% | -42% | -54.23% | -56.69% | -65.63% | -48% | -42.14% | -51.45% | -54.98% |
| D&A (Non-Cash Add-back) | 1.16M | 994K | 1.01M | 959K | 925K | 788K | 770K | 753K | 474K | 262K | 273K | 280K | 283K | 280K | 248K | 215K | 240K | 235K | 233K | 230K |
| EBIT | -140.38M | -133.67M | -142.59M | -129.11M | -111.41M | -94.75M | -87.8M | -82.78M | -73.53M | -62.66M | -58.98M | -52.99M | -47.98M | -47.56M | -43.45M | -43.05M | -33.83M | -30.89M | -27.81M | -26.09M |
| Net Interest Income | 12.66M | 11.16M | 12.54M | 13.46M | 14.83M | 14.37M | 11.01M | 8.74M | 7.32M | 6.72M | 2.57M | 2.11M | 2.04M | 1.9M | 1.5M | 720K | 193K | 80K | 24K | 23K |
| Interest Income | 12.66M | 11.16M | 12.54M | 13.46M | 14.83M | 14.37M | 11.01M | 8.74M | 7.32M | 6.72M | 2.57M | 2.11M | 2.04M | 1.9M | 1.5M | 720K | 193K | 80K | 24K | 23K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 12.53M | 11.03M | 12.49M | 13.47M | 14.63M | 14.15M | 10.97M | 8.73M | 6.6M | 2.56M | 1.52M | 2.02M | 1.98M | 2.56M | 1.53M | 670K | -800K | 94K | -44K | -6K |
| Pretax Income | -127.84M | -122.64M | -130.09M | -115.64M | -96.77M | -80.59M | -76.83M | -74.06M | -66.93M | -60.1M | -57.46M | -50.98M | -45.99M | -44.99M | -41.92M | -42.38M | -34.63M | -30.79M | -27.85M | -26.09M |
| Pretax Margin % | -1191.03% | -1990.5% | -90972.73% | -11216% | -26807.2% | - | - | -18560.15% | -10457.81% | - | -16606.36% | -5159.82% | -1716.87% | -6345.7% | -9153.93% | -9652.62% | -1105.94% | -2856.59% | - | - |
| Income Tax | 0 | 180K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -0.15% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -127.84M | -122.81M | -130.09M | -115.64M | -96.77M | -80.59M | -76.83M | -74.06M | -66.93M | -60.1M | -57.46M | -50.98M | -45.99M | -44.99M | -41.92M | -42.38M | -34.63M | -30.79M | -27.85M | -26.09M |
| Net Margin % | -1191.03% | -1993.43% | -90972.73% | -11216% | -26807.2% | - | - | -18560.15% | -10457.81% | - | -16606.36% | -5159.82% | -1716.87% | -6345.7% | -9153.93% | -9652.62% | -1105.94% | -2856.59% | - | - |
| Net Income Growth % | -32.11% | -52.39% | -69.33% | -56.15% | -44.59% | -34.11% | -33.71% | -45.27% | -45.52% | -33.58% | -37.05% | -20.3% | -32.83% | -46.1% | -50.53% | -62.39% | -51.2% | -42.29% | -52.03% | -58.24% |
| Net Income (Continuing) | -127.84M | -122.81M | -130.09M | -115.64M | -96.77M | -80.59M | -76.83M | -74.06M | -66.93M | -60.1M | -57.46M | -50.98M | -45.99M | -44.99M | -41.92M | -42.38M | -34.63M | -30.79M | -27.85M | -26.09M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.23 | -1.30 | -1.38 | -1.23 | -1.04 | -0.88 | -0.96 | -0.94 | -0.93 | -0.89 | -1.01 | -0.94 | -0.82 | -0.79 | -0.75 | -0.79 | -0.74 | -0.68 | -0.73 | -0.70 |
| EPS Growth % | -18.27% | -47.73% | -43.75% | -30.85% | -11.83% | 1.12% | 4.95% | 0% | -13.41% | -12.66% | -34.67% | -18.99% | -10.81% | -16.18% | -2.74% | -12.86% | -7.25% | -3.03% | -30.36% | -32.08% |
| EPS (Basic) | -1.23 | -1.30 | -1.38 | -1.23 | -1.04 | -0.88 | -0.96 | -0.94 | -0.93 | -0.89 | -1.01 | -0.94 | -0.82 | -0.79 | -0.75 | -0.79 | -0.75 | -0.68 | -0.73 | -0.70 |
| Diluted Shares Outstanding | 104.1M | 94.06M | 94.22M | 93.79M | 93.1M | 91.49M | 80.09M | 79.01M | 72.29M | 67.15M | 56.81M | 54.27M | 53.91M | 53.84M | 53.77M | 52.52M | 47.71M | 45.23M | 38.31M | 37.06M |
| Basic Shares Outstanding | 104.1M | 94.06M | 94.22M | 93.79M | 93.1M | 91.49M | 80.09M | 79.01M | 72.29M | 67.15M | 56.81M | 54.27M | 53.91M | 53.84M | 53.77M | 52.52M | 47.43M | 45.23M | 38.31M | 37.06M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |